Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1-(2-((4-chloro-alpha-phenylbenzyl)oxy)ethyl)piperidine
2. Cloperastine
1. 14984-68-0
2. Cloperastine Hcl
3. Seki
4. 1-(2-((4-chlorophenyl)(phenyl)methoxy)ethyl)piperidine Hydrochloride
5. Pi4n7c63nd
6. Cloperastine Hydrochloride [jan]
7. Cloperastine (hydrochloride)
8. 1-[2-[(4-chlorophenyl)-phenylmethoxy]ethyl]piperidine;hydrochloride
9. Dsstox_cid_25413
10. Dsstox_rid_80863
11. Dsstox_gsid_45413
12. 1-[2-[(4-chlorophenyl)(phenyl)methoxy]ethyl]piperidine Hydrochloride
13. Cloperastina Cloridrato
14. Cloperastina Cloridrato [italian]
15. Piperidine, 1-(2-((4-chlorophenyl)phenylmethoxy)ethyl)-, Hydrochloride
16. Sr-01000841238
17. Einecs 239-067-8
18. Unii-pi4n7c63nd
19. 1-(2-((p-chloro-a-phenylbenzyl)oxy)ethyl)piperidine Hydrochloride
20. Piperidine, 1-(2-((4-chlorophenyl)phenylmethoxy)ethyl)-, Hydrochloride (1:1)
21. Piperidine, 1-[2-[(4-chlorophenyl)phenylmethoxy]ethyl]-, Hydrochloride (1:1)
22. Prestwick_74
23. Ht-11 Hydrochloride
24. 2-piperidinoethyl P-chlorobenzhydryl Ether Hydrochloride
25. Cloperastine Hydrocloride
26. Ncgc00016711-01
27. 1-(2-((p-chloro-alpha-phenylbenzyl)oxy)ethyl)piperidine Hydrochloride
28. 1-(2-(p-cloro-alpha-fenilbenzilossi)etil)piperidina Cloridrato [italian]
29. Cas-14984-68-0
30. Schembl23733
31. Mls002154004
32. Spectrum1503920
33. Cloperastinehydrochloride
34. Chembl1492516
35. Dtxsid5045413
36. Chebi:31420
37. 4-chlorobenzhydryl 2-(1-piperidyl)ethyl Ether Hydrochloride
38. Hms1570o08
39. Hms1922k14
40. Pharmakon1600-01503920
41. Cloperastine Hydrochloride (jp17)
42. 1-(2-((4-chlorophenyl)phenylmethoxy)ethyl)piperidinium Chloride
43. 1-(2-(p-cloro-alpha-fenilbenzilossi)etil)piperidina Cloridrato
44. Bcp13748
45. Hy-b2133
46. Tox21_110575
47. Ccg-39374
48. Mfcd00079012
49. Nsc758635
50. S5479
51. Akos015961657
52. Piperidine, 1-(2-((p-chloro-alpha-phenylbenzyl)oxy)ethyl)-, Hydrochloride
53. Tox21_110575_1
54. Cloperastine Hydrochloride [mi]
55. Ncgc00095079-01
56. Ncgc00095079-02
57. Ncgc00178069-05
58. Ac-14456
59. Bs-21517
60. Cloperastine Hydrochloride [mart.]
61. Smr001233333
62. Cloperastine Hydrochloride [who-dd]
63. Db-043018
64. Cs-0020289
65. Ft-0603201
66. Cloperastine Hydrochloride, Analytical Standard
67. D01609
68. D70218
69. 984c680
70. Q-200881
71. Sr-01000841238-2
72. Sr-01000841238-3
73. Q27286572
74. 1-{2-[(4-chloro-phenyl)-phenyl-methoxy]-ethyl}-piperidine Hydrochloride
75. 1-(2-((p-chloro-.alpha.-phenylbenzyl)oxy)ethyl)piperidine Hydrochloride
| Molecular Weight | 366.3 g/mol |
|---|---|
| Molecular Formula | C20H25Cl2NO |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 6 |
| Exact Mass | 365.1313198 g/mol |
| Monoisotopic Mass | 365.1313198 g/mol |
| Topological Polar Surface Area | 12.5 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 318 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
ABOUT THIS PAGE
A Cloperastine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cloperastine, including repackagers and relabelers. The FDA regulates Cloperastine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cloperastine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cloperastine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cloperastine supplier is an individual or a company that provides Cloperastine active pharmaceutical ingredient (API) or Cloperastine finished formulations upon request. The Cloperastine suppliers may include Cloperastine API manufacturers, exporters, distributors and traders.
click here to find a list of Cloperastine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cloperastine Drug Master File in Japan (Cloperastine JDMF) empowers Cloperastine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cloperastine JDMF during the approval evaluation for pharmaceutical products. At the time of Cloperastine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cloperastine suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cloperastine Drug Master File in Korea (Cloperastine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cloperastine. The MFDS reviews the Cloperastine KDMF as part of the drug registration process and uses the information provided in the Cloperastine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cloperastine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cloperastine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cloperastine suppliers with KDMF on PharmaCompass.
Cloperastine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cloperastine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cloperastine GMP manufacturer or Cloperastine GMP API supplier for your needs.
A Cloperastine CoA (Certificate of Analysis) is a formal document that attests to Cloperastine's compliance with Cloperastine specifications and serves as a tool for batch-level quality control.
Cloperastine CoA mostly includes findings from lab analyses of a specific batch. For each Cloperastine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cloperastine may be tested according to a variety of international standards, such as European Pharmacopoeia (Cloperastine EP), Cloperastine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cloperastine USP).
LOOKING FOR A SUPPLIER?
